Navigation Links
Perrigo Company To Present At The Credit Suisse Healthcare Conference
Date:11/13/2012

ALLEGAN, Mich., Nov. 13, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Credit Suisse Healthcare Conference on Wednesday, November 14, 2012 at The Arizona Biltmore Hotel in Phoenix, AZ at 4:30 PM (MST).

From its beginnings as a packager of generic home remedies in 1887, Perrigo Company, based in Allegan, Michigan, has grown to become a leading global provider of quality, affordable healthcare products. The Company develops, manufactures and distributes over-the-counter ("OTC") and generic prescription ("Rx") pharmaceuticals, nutritional products and active pharmaceutical ingredients ("API") and is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. Perrigo's mission is to offer uncompromised "quality, affordable healthcare products", and it does so across a wide variety of product categories primarily in the United States, United Kingdom, Mexico, Israel and Australia, as well as certain other markets throughout the world, including Canada, China and Latin America. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections.  While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 30, 2012, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Reports Record First Quarter Revenue And Adjusted Earnings And Raises Full Year Adjusted EPS Guidance
2. Perrigo Company Announces Appointment Of New Board Of Directors Member
3. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million
4. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
5. Perrigo Company Announces Quarterly Dividend
6. Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
7. Perrigo Company To Present At The William Blair Growth Stock Conference
8. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
9. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
10. Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
11. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Feb. 27, 2017 Pulmonary drug delivery market ... from USD 36.10 billion in 2016, at a CAGR ... pulmonary route as an alternate route of drug delivery, ... increasing incidence of respiratory diseases such as COPD, asthma, ... growth during the forecast period. However, emerging markets and ...
(Date:2/28/2017)... -- Clarivate Analytics marks the passing of one if its founding fathers, Dr. ... science in the service of scientific and scholarly research. A pioneer in ... that revolutionized the way researchers work with the literature, Garfield passed away ... ... Dr. Eugene Garfield, ...
(Date:2/28/2017)... Research and Markets has announced the addition of the ... their offering. ... The global digestive enzyme supplements market is expected ... regarding the severity of digestive disorders coupled with the need ... the forecast period. The increasing incidence of gastrointestinal tract diseases, ...
Breaking Medicine Technology:
(Date:2/28/2017)... , ... February 28, 2017 , ... Las Vegas Skin ... South Rancho location on Friday, March 10, 2017, 4-7 pm PST. For more than ... this clinic, located in the South Rancho neighborhood, has been renovated to provide medical ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... decade, has challenges as they transition from military to civilian life. Body image ... two million who experience poorer health and greater occurrence of chronic mental health ...
(Date:2/27/2017)... Houston, Texas (PRWEB) , ... February 27, 2017 ... ... leader in the alternative health care industry, announces Chris Brandl as its New ... has brought vision and purpose to corporations throughout his career. He began his ...
(Date:2/27/2017)... ... , ... The threat of nuclear warfare has long plagued this world. In ... underground testing of nuclear weapons. Years later, when her co-workers began dying, Dot started ... Nuclear Testing,” Clayton exposes the critical decisions made by agencies involved in the nuclear ...
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate ... and video system brings songs, movies, TV shows and much more apps for user ... high-definition sound. An immersive view of 1280 x 720 provides crisp images with remarkable ...
Breaking Medicine News(10 mins):